Study identifier:SD-005-0689
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A comparison of the nasal mucosal tissue concentrations of budesonide, budesonide oleate, budesonide palmitate and mometasone furoate in seasonal allergic rhinitis patients out of season
Allergic Rhinitis
Phase 1
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|